Trial Details

Not Recruiting
Basic Information
Clinical ID c4892
Identifier JPRN-UMIN000022575
Trial Title Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease - Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Ulcerative colitis,Crohn disease
Interventions Patients take oral Qing-Dai in capsule form twice a day(daily dose,2g)for 4 weeks.If patients achieve clinical remission or show clinical response,they will be allowed to continue taking these drugs for 52 weeks.
Participant Information
Sponsor Kyushu University
City NULL
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL